Knowles Corporation reports developments tied to its specialty electronic components business, including high-performance capacitors, RF and microwave filters, advanced medtech microphones, balanced armature speakers, and miniaturization products. Company updates focus on quarterly operating results, outlook, design-win activity, backlog, and demand across medtech, defense, industrial, and electrification end markets.
Recurring news also covers management conference participation and the company's continuing portfolio focus after the completed sale of its Consumer MEMS Microphone business. Knowles describes its model around custom engineering, reliable components, and scalable manufacturing for applications that require specialized electronic performance.
Knowles (KN) reported third-quarter 2026 revenue of $184.0 million, up 20% year over year and above its guidance range. Diluted earnings per share from continuing operations rose to $0.24 from $0.21 a year earlier; non-GAAP diluted earnings per share increased to $0.38 from $0.33. Operating cash flow reached $44.6 million, versus $29.1 million. Gross margin fell to 44.2% from 45.7%, despite higher gross profit.
For the quarter ending December 31, 2026, Knowles expects revenue of $180–$190 million, diluted earnings per share from continuing operations of $0.31–$0.35, and operating cash flow of $60–$70 million. Full-year revenue is estimated at $689 million, up 16% versus 2025, at the fourth-quarter revenue guidance midpoint. Precision Devices recorded an orders-to-revenue ratio above one for the eighth consecutive quarter.
Knowles (KN) introduced its ATT A-Series attenuators, expanding its radio-frequency component portfolio with compact surface-mount devices that reduce signal levels. The company positions the launch as part of its strategy to offer a more complete RF solution.
The devices operate from DC to 20 GHz and offer standard attenuation values from 0 dB to 20 dB. Power handling is rated up to 6.5 W CW at 100°C, meaning continuous-wave operation. Custom attenuation values, power ratings and specialized configurations are also available through Knowles' design-to-spec services.
Knowles (KN) will release its third-quarter 2026 financial results after the market closes on October 22, 2026.
A conference call to discuss the results and company outlook is scheduled for 3:30 p.m. Central time (4:30 p.m. Eastern time). A webcast replay will be available afterward on the Knowles website.
Knowles (NYSE: KN) announced an agreement to manufacture Elucent Medical's smart surgical guidance device used with Elucent's EnVisio In-Body Spatial Intelligence System. Knowles was selected for its micro molding capabilities, design-for-manufacturability expertise, and vertically integrated assembly to support device design, development, and launch.
According to Knowles, its teams collaborated closely with Elucent to iterate designs, improve tolerances and materials, and enhance production readiness, quality, scalability, and time-to-market. Manufacturing is conducted at an ISO 13485-certified and FDA-registered Knowles facility in Penang, Malaysia, leveraging a broad medtech-focused precision manufacturing portfolio.
Knowles (NYSE: KN) reported Q2 2026 revenues from continuing operations of $166.8 million, up 14% year over year, with GAAP diluted EPS from continuing operations of $0.21, up $0.12, and non-GAAP diluted EPS of $0.33, up 38% year over year. GAAP gross margin reached 44.7%, while non-GAAP gross margin was 45.4%. Net cash provided by operating activities was $28.2 million.
For the six months ended June 30, 2026, revenue was $319.9 million versus $278.1 million a year earlier, and diluted EPS from continuing operations was $0.34 compared with $0.08. According to Knowles, full-year 2026 revenues are now expected to grow 10–12% with adjusted EBITDA growth of more than 20%. Q3 2026 guidance calls for revenues of $167–$177 million, GAAP diluted EPS of $0.22–$0.26, non-GAAP diluted EPS of $0.34–$0.38, and operating cash flow of $35–$45 million.
Knowles (NYSE:KN) will release its second quarter 2026 financial results on July 23, 2026, after market close. The company will host a conference call at 3:30 p.m. Central (4:30 p.m. Eastern) to discuss results and outlook.
Investors can join via toll and toll-free numbers or a live webcast, with a replay available on the Knowles investor relations website.
Knowles (NYSE: KN) reported Q1 2026 revenues of $153.1 million, up 16% year-over-year, and Q1 non-GAAP diluted EPS of $0.27, up 50% year-over-year. Gross margin expanded to 45.5% on a non-GAAP basis.
For Q2 2026 the company guided revenues $152–$162 million, GAAP EPS $0.18–$0.22 and non-GAAP EPS $0.28–$0.32, with expected operating cash flow of $20–$30 million.
Knowles (NYSE: KN) will participate in investor conferences in May 2026. John Anderson, CFO, will attend the 2nd Annual Spring One-on-One Virtual Conference on Wednesday, May 13, 2026. Knowles will also participate in The J.P. Morgan Global Technology, Media and Communications Conference in Boston on May 18-19, 2026, with a company presentation on Monday, May 18 at 4:10pm ET.
Investors should contact their CJS Securities or J.P. Morgan representative to schedule meetings with management.
Knowles (NYSE: KN) will release its first quarter 2026 financial results on April 23, 2026 immediately after market close, followed by a conference call at 3:30 p.m. Central time (4:30 p.m. Eastern).
Analysts and investors may join via dial‑in (Conference ID 8193117) or webcast. A replay and webcast replay will be available through April 30, 2026.
Knowles (NYSE: KN) reported Q4 2025 revenues $162.2M (+14% YoY) and FY 2025 revenues $593.2M (+7% YoY). Gross margin was 44.7% in Q4; non-GAAP diluted EPS was $1.11 for FY 2025. Full year net cash from operations was $114.0M (19.2% of revenues).
Management reiterated Q1 2026 guidance of $143–$153M revenues, GAAP EPS $0.09–$0.13 (non-GAAP $0.22–$0.26), and operating cash of $(5)–$5M.